ATE256134T1 - Sulfatierte phosphatidylinositole, ihre herstellung und verwendung - Google Patents

Sulfatierte phosphatidylinositole, ihre herstellung und verwendung

Info

Publication number
ATE256134T1
ATE256134T1 AT00903264T AT00903264T ATE256134T1 AT E256134 T1 ATE256134 T1 AT E256134T1 AT 00903264 T AT00903264 T AT 00903264T AT 00903264 T AT00903264 T AT 00903264T AT E256134 T1 ATE256134 T1 AT E256134T1
Authority
AT
Austria
Prior art keywords
sulfated
pharmaceutical compositions
phosphatidylinositols
production
sulfated phosphatidylinositol
Prior art date
Application number
AT00903264T
Other languages
English (en)
Inventor
Eric J Dadey
Xiao-Hui Mei
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of ATE256134T1 publication Critical patent/ATE256134T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00903264T 1999-01-15 2000-01-12 Sulfatierte phosphatidylinositole, ihre herstellung und verwendung ATE256134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11616699P 1999-01-15 1999-01-15
PCT/US2000/000749 WO2000042050A1 (en) 1999-01-15 2000-01-12 Sulfated phosphatidylinositols, their preparation and use

Publications (1)

Publication Number Publication Date
ATE256134T1 true ATE256134T1 (de) 2003-12-15

Family

ID=22365644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903264T ATE256134T1 (de) 1999-01-15 2000-01-12 Sulfatierte phosphatidylinositole, ihre herstellung und verwendung

Country Status (12)

Country Link
US (1) US6316424B1 (de)
EP (1) EP1144420B1 (de)
JP (1) JP2002534528A (de)
AT (1) ATE256134T1 (de)
AU (1) AU2503900A (de)
BR (1) BR0007513A (de)
CA (1) CA2356306C (de)
DE (1) DE60007074T2 (de)
DK (1) DK1144420T3 (de)
ES (1) ES2214249T3 (de)
PT (1) PT1144420E (de)
WO (1) WO2000042050A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020065927A1 (en) 2000-09-05 2002-05-30 Janik Craig M. Webpad and method for using the same
US20050084513A1 (en) * 2003-10-21 2005-04-21 Board Of Regents Nanocoating for improving biocompatibility of medical implants
US20050239747A1 (en) * 2004-04-21 2005-10-27 Pharmaceutical Industry Technology And Development Center Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods
TW200846031A (en) * 2007-05-25 2008-12-01 Shu-Yi Lin Drug delivery system and the preparing method thereof
EP2231694A4 (de) * 2007-12-18 2010-12-29 Agency Science Tech & Res Kationische kern-hülle-peptid-nanopartikel
US8715987B2 (en) * 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
CN108586574B (zh) * 2018-04-26 2019-11-12 国家海洋局第三海洋研究所 氨基葡萄糖肽类化合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293826A3 (de) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutische und prophylaktische Gabe von sulfatierten Polysacchariden gegen AIDS
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US6602861B1 (en) * 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
AU737680C (en) * 1996-05-16 2002-05-02 Nissin Foods Holdings Co., Ltd. Novel compounds having antiviral activity

Also Published As

Publication number Publication date
DE60007074T2 (de) 2004-09-16
DE60007074D1 (de) 2004-01-22
PT1144420E (pt) 2004-04-30
DK1144420T3 (da) 2004-04-13
JP2002534528A (ja) 2002-10-15
CA2356306A1 (en) 2000-07-20
ES2214249T3 (es) 2004-09-16
WO2000042050A1 (en) 2000-07-20
AU2503900A (en) 2000-08-01
CA2356306C (en) 2006-02-21
US6316424B1 (en) 2001-11-13
BR0007513A (pt) 2001-11-20
EP1144420A1 (de) 2001-10-17
EP1144420B1 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE401892T1 (de) Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
NO962088D0 (no) Preparat for in vivo-produksjon av terapeutiske produkter
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE69940674D1 (de) Orale verabreichung von adenosin analogen
NZ501950A (en) Medicinal compositions for application to mucosa
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
DE60126433D1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
ATE292453T1 (de) Antivirale arznei
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
EA200200914A1 (ru) Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
GEP20043377B (en) Pharmaceutical Complex
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
GB0018322D0 (en) Pharmaceutical compositions
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1144420

Country of ref document: EP

REN Ceased due to non-payment of the annual fee